Cargando…

Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer

Although multigene panel testing is increasingly common in patients with cancer, the relationship between its use among breast cancer patients with non‐BRCA mutations or variants of uncertain significance (VUS) and disease management decisions has not been well described. This study evaluated the ra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elsayegh, Nisreen, Webster, Rachel D., Gutierrez Barrera, Angelica M., Lin, Heather, Kuerer, Henry M., Litton, Jennifer K., Bedrosian, Isabelle, Arun, Banu K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Cancer Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010764/ https://www.ncbi.nlm.nih.gov/pubmed/29733510 http://dx.doi.org/10.1002/cam4.1519

Ejemplares similares

Predictors that Influence Election of Contralateral Prophylactic Mastectomy among Women with Ductal Carcinoma in Situ who are BRCA-Negative
por: Elsayegh, Nisreen, et al.
Publicado: (2015)

Contralateral prophylactic mastectomy: current perspectives
por: Yao, Katharine, et al.
Publicado: (2016)

Evaluation of BRCAPRO Risk Assessment Model in Patients with Ductal Carcinoma In situ Who Underwent Clinical BRCA Genetic Testing
por: Elsayegh, Nisreen, et al.
Publicado: (2016)

Contralateral Prophylactic Mastectomy among Women with Pathogenic Variants in BRCA1/2: Overall Survival, Racial, and Ethnic Differences
por: Makhnoon, Sukh, et al.
Publicado: (2022)

Influencers of the Decision to Undergo Contralateral Prophylactic Mastectomy among Women with Unilateral Breast Cancer
por: Singareeka Raghavendra, Akshara, et al.
Publicado: (2021)

Abstract: Contralateral Prophylactic Mastectomy: The Argument for Bilateral Mastectomies and Reconstruction
por: Schultz, Benjamin D., et al.
Publicado: (2018)

Second primary breast cancer after unilateral mastectomy alone or with contralateral prophylactic mastectomy
por: Agarwal, Shailesh, et al.
Publicado: (2020)

Better contralateral breast cancer risk estimation and alternative options to contralateral prophylactic mastectomy
por: Davies, Kalatu R, et al.
Publicado: (2015)

Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033)
por: Davies, Kalatu R., et al.
Publicado: (2016)

Motivations for contralateral prophylactic mastectomy as a function of socioeconomic status
por: Baptiste, Dadrie F., et al.
Publicado: (2017)

Contralateral prophylactic mastectomy in male breast cancer: where do we stand?
por: Sciarra, Antonella, et al.
Publicado: (2021)

Effect of rurality and travel distance on contralateral prophylactic mastectomy for unilateral breast cancer
por: Wahlen, Madison M., et al.
Publicado: (2023)

Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability
por: Scheepens, Josien C.C., et al.
Publicado: (2021)

Disparities in contralateral prophylactic mastectomy use among women with early-stage breast cancer
por: Kim, Younji, et al.
Publicado: (2017)

Preserving choice in breast cancer treatment: A different perspective on contralateral prophylactic mastectomy
por: Pender, Kelly, et al.
Publicado: (2023)

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers
por: van Sprundel, T C, et al.
Publicado: (2005)

Trends in contralateral prophylactic mastectomy rate according to clinicopathologic and socioeconomic status
por: Jeon, Ho Jong, et al.
Publicado: (2019)

Social Network, Surgeon, and Media Influence on the Decision to Undergo Contralateral Prophylactic Mastectomy
por: Venetis, Maria K., et al.
Publicado: (2018)

Clinical features, prognosis, and influencing factors of contralateral prophylactic mastectomy in 58 patients with breast cancer
por: Zheng, Yiqiong, et al.
Publicado: (2020)

Nationwide Trends in Contralateral Prophylactic Mastectomies: An Analysis of 55,060 Unilateral Breast Cancer Patients
por: Shaheen, Mohammed S., et al.
Publicado: (2022)

Immediate Implant-Based Reconstruction of the Contralateral or Bilateral Prophylactic Mastectomies: Risk Factor Analysis for Index and Prophylactic Breast
por: Dolen, Utku Can, et al.
Publicado: (2020)

Multigene Panel Testing for Hereditary Cancer Risk
por: Grissom, Alyssa A., et al.
Publicado: (2016)

Patient opinions on contralateral prophylactic mastectomy: A patient-driven discussion in need of tuning?
por: Brown, Zachary M., et al.
Publicado: (2022)

Trends in utilization of contralateral prophylactic mastectomy among different age, racial and ethnic groups
por: Owusu-Brackett, Nicci, et al.
Publicado: (2023)

Clinical outcome for BRCA1 and BRCA2 mutation carriers after contralateral prophylactic mastectomy
por: Schmidt, MK, et al.
Publicado: (2005)

Abstract 71: Postoperative Quality of Life in Patients Undergoing Contralateral Prophylactic Mastectomy with Breast Reconstruction
por: Rizzo, Amanda M., et al.
Publicado: (2018)

Application of Multigene Panels Testing for Hereditary Cancer Syndromes
por: Bilyalov, Airat, et al.
Publicado: (2022)

Prophylactic mastectomy for the prevention of breast cancer: Review of the literature
por: Alaofi, Rawan K., et al.
Publicado: (2018)

Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomy
por: Tan, Murly BM, et al.
Publicado: (2009)

Effectiveness of Prophylactic Mastectomy
por: Berkeš, Andrej, et al.
Publicado: (2023)

Multigene Panel Testing in Turkish Hereditary Cancer Syndrome Patients
por: ARSLAN ATES, Esra, et al.
Publicado: (2022)

Coordinated prophylactic surgical management for women with hereditary breast-ovarian cancer syndrome
por: Batista, Larissa I, et al.
Publicado: (2008)

3275 Nonclinical factors associated with contralateral prophylactic mastectomy among breast cancer patients in the Surveillance, Epidemiology, and End Results (SEER) database
por: Copeland, Timothy Paul, et al.
Publicado: (2019)

Population prevalence of individuals meeting criteria for hereditary breast and ovarian cancer testing
por: Greenberg, Samantha, et al.
Publicado: (2019)

Plastic and Reconstructive Surgeons' Knowledge and Comfort of Contralateral Prophylactic Mastectomy: A Survey of the American Society of Plastic Surgeons
por: Lopez, Christopher D., et al.
Publicado: (2019)

Abstract 9. Morbidity and Quality of Life Outcomes of Breast Reconstruction for Unilateral Mastectomy vs. Additional Contralateral Prophylactic Mastectomy: a Cohort Study of 211 Breast Reconstruction Patients Morbidity and Quality of Life Outcomes of Breast Reconstruction for Unilateral Mastectomy vs. Additional Contralateral Prophylactic Mastectomy: a Cohort Study of 211 Breast Reconstruction Patients
por: Sebai, Mohamad E., et al.
Publicado: (2017)

Factors associated with contralateral preventive mastectomy
por: Yakoub, Danny, et al.
Publicado: (2015)

Identification of hereditary cancer in the general population: development and validation of a screening questionnaire for obtaining the family history of cancer
por: Campacci, Natalia, et al.
Publicado: (2017)

Contralateral Prophylactic Mastectomy in Women with Unilateral Breast Cancer Who Are Genetic Carriers, Have a Strong Family History or Are just Young at Presentation
por: Teoh, Victoria, et al.
Publicado: (2020)

Nomogram Predicts the Role of Contralateral Prophylactic Mastectomy in Male Patients With Unilateral Breast Cancer Based on SEER Database: A Competing Risk Analysis
por: Li, Kunlong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qcfo4da41snk7s6lgp3k1mp6cu